Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Nov:66:109926.
doi: 10.1016/j.jclinane.2020.109926. Epub 2020 May 26.

Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease

Manuel Taboada  1 , Valentín Caruezo  2 , Alberto Naveira  2 , Peter G Atanassoff  3
Affiliations
Case Reports

Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease

Manuel Taboada et al. J Clin Anesth. 2020 Nov.
No abstract available

Keywords: Acute respiratory distress syndrome (ARDS); COVID-19; Corticosteroids; Severe respiratory distress.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare the absence of conflict of interests.

Figures

Fig. 1
Fig. 1
Timeline of disease course according to days from Hospital admission, and days from ICU admission, from 31 March to 22 April. Serum ferritin (μ/L); lymphocytes (mer mm3); D-dimer (ng/mL); C-reactive protein (mg/L); PP: prone positioning; HFCN: high-flow nasal cannula; dexamethasone (20 mg 5 days, 10 mg 5 days); methylprednisolone (1 mg/kg/day); low dose methylprednisolone (20 mg/day).
See this image and copyright information in PMC

References

    1. Villar J., Ferrando C., Martínez D. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020 Mar;8(3):267–276. doi: 10.1016/S2213-2600(19)30417-5. [Epub 2020 Feb 7] - DOI - PubMed
    1. Nicastri E., Petrosillo N., Bartoli T.A. National Institute for the infectious diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management. Infect Dis Rep. 2020 Mar 16;12(1):8543. doi: 10.4081/idr.2020.8543. [eCollection 2020 Feb 25] - DOI - PMC - PubMed
    1. Meduri G.U., Bridges L., Siemieniuk R.A.C., Kocak M. An exploratory reanalysis of the randomized trial on efficacy of corticosteroids as rescue therapy for the late phase of acute respiratory distress syndrome. Crit Care Med. 2018 Jun;46(6):884–891. doi: 10.1097/CCM.0000000000003021. - DOI - PubMed
    1. Siddiqi H.K., Mehra M.R. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal [published online ahead of print, 2020 Mar 20] J Heart Lung Transplant. 2020 doi: 10.1016/j.healun.2020.03.012. - DOI - PMC - PubMed
    1. Xu Z., Shi L., Wang Y. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr;8(4):420–422. doi: 10.1016/S2213-2600(20)30076-X. [Epub 2020 Feb 18] - DOI - PMC - PubMed

MeSH terms

Substances